Metabolic Syndrome and Its Related Diseases in Healthcare Workers: Incidence, Prevalence, and Risk Factors
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Metabolic Syndrome X
- Sponsor
- Peking Union Medical College Hospital
- Enrollment
- 7432
- Locations
- 1
- Primary Endpoint
- composite endpoint of cardiovascular and cerebrovascular diseases
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
This study aims to investigate the incidence and prevalence of metabolic syndrome and metabolism-related diseases among healthcare workers, identify potential risk factors for these diseases, evaluate the control status of these conditions, and explore the significance of annual regular check-ups in improving metabolic-related health outcomes. All data for the study subjects are sourced from anonymized continuous records in hospital physical examinations and medical case files. The study does not involve any interventions. Upon obtaining the study data, researchers will use retrospective analysis methods to identify possible associations between risk factors and diseases.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age ≥18 years
- •Healthcare workers who attend annual check-ups at Peking Union Medical College Hospital
Exclusion Criteria
- •Presence of metabolic syndrome, hypertension, diabetes, coronary heart disease, or stroke at the time of the first physical examination between 2012 and 2022
- •Malignant neoplasm
- •Liver failure
- •Moderate to severe heart failure
Outcomes
Primary Outcomes
composite endpoint of cardiovascular and cerebrovascular diseases
Time Frame: through study completion, an average of 5 years
The number of hospitalizations due to severe coronary heart disease, stroke, or sudden cardiac death. The outcome is determined if any of the first three discharge diagnoses include acute myocardial infarction, stroke, or sudden cardiac death, or if an emergency coronary stent placement or coronary artery bypass graft surgery is performed during hospitalization.
Secondary Outcomes
- new-onset metabolic syndrome(through study completion, an average of 5 years)